Transgene Biotek Ltd

NSE: TRABI · BSE: 526139 · Healthcare · 20 announcements

Share price: ₹2.59
Market cap: ₹19.62 Cr
Revenue (annual): ₹0.21 Cr
Net profit (annual): ₹-1.65 Cr
P/E (TTM): -12.2×Sector 54.5×
Promoter holding: 23.64%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Financial Results 4 Management Change 3 Board Meeting Date 3 Fund Raise 1 Debt & Borrowing 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Apr 2026 18:01 IST BSE

Fund Raise

Transgene Biotek Fund Raise

Transgene Biotek Ltd submitted a NIL statement regarding Regulation 32(1) for the quarter ended March 31, 2026. The company confirmed no funds were raised through public, rights, or preferential issues during the period, resulting in no deviation or variation in fund utilization. This is a routine regulatory compliance filing.

Open announcement → Read the filing ↗